Carriquiry M, Weber W J, Fahrenkrug S C, Crooker B A
Department of Animal Science, University of Minnesota, St Paul 55108-6118, USA.
J Dairy Sci. 2009 Oct;92(10):4889-900. doi: 10.3168/jds.2008-1676.
Multiparous cows were fed supplemental dietary fat and treated with bST to assess effects of n-3 fatty acid supply, bovine somatotropin (bST), and stage of lactation on hepatic gene expression. Cows were blocked by expected calving date and previous milk yield and assigned randomly to treatment. Supplemental dietary fat was provided from calving as either whole high-oil sunflower seeds (SS; 10% of dietary dry matter; n-6/n-3 ratio of 4.6) as a source of linoleic acid or a mixture of Alifet-High Energy and Alifet-Repro (AF; 3.5 and 1.5% of dietary dry matter, respectively; n-6/n-3 ratio of 2.6) as a source of protected n-3 fatty acids. Cows were treated with 0 (SSN, AFN) or 500 (SSY, AFY) mg of bST every 10 d from 12 to 70 d in milk (DIM) and at 14-d intervals thereafter. Liver biopsies were collected on -12, 10, 24, and 136 DIM for gene expression analysis. Growth hormone receptor (GHR), insulin-like growth factor-I (IGF-I), IGF-binding protein-3 (IGFBP3), hepatic nuclear factor 4alpha (HNF4alpha), fibroblast growth factor-21 (FGF-21), and peroxisome proliferator-activated receptor alpha (PPARalpha) were the target genes and hypoxanthine phosphoribosyltransferase (HPRT) was used as an endogenous control gene. Expression was measured by quantitative real-time reverse transcription-PCR analyses of 4 samples from each of 32 cows (8 complete blocks). Amounts of hepatic HPRT mRNA were not affected by bST or diet but were increased by approximately 3.8% in early lactation (3.42, 3.52, 3.54, and 3.41 x 10(4) message copies for -12, 10, 24, and 136 DIM, respectively). This small change had little detectable impact on the ability of HPRT to serve as an internal control gene. Amounts of hepatic GHR, IGF-I, and IGFBP3 mRNA were reduced by 1.5 to 2-fold after calving. Expression of GHR and IGF-I increased and IGFBP3 tended to increase within 12 d (by 24 DIM) of bST administration. These effects of bST persisted through 136 DIM. Hepatic HNF4alpha mRNA was not altered by DIM or any of the treatments. Abundance of PPARalpha mRNA was unchanged through 24 DIM but increased by 136 DIM. There was a trend for an interaction of bST, diet, and DIM on PPARalpha mRNA abundance from 24 to 136 DIM because the amount of PPARalpha mRNA increased in SSN, SSY, and AFN cows but was not altered in AFY cows. The amount of FGF-21 mRNA increased markedly in early lactation but, like HNF4alpha mRNA, was not affected by bST, diet, or their interactions. These results indicate 1) that bST induced increases in hepatic expression of GHR, IGF-I, and IGFBP3 when cows were in negative energy balance in early lactation, 2) there was no effect of reduced dietary n-6/n-3 content on hepatic gene expression, and 3) there was support for a potential homeorhetic role of hepatic FGF-21 via uncoupling the somatotropin-IGF-axis in early lactation.
对经产奶牛补充日粮脂肪并使用牛生长激素(bST)进行处理,以评估n-3脂肪酸供应、牛生长激素(bST)和泌乳阶段对肝脏基因表达的影响。奶牛按预期产犊日期和先前产奶量进行分组,并随机分配处理。从产犊开始提供补充日粮脂肪,要么是作为亚油酸来源的全脂高油向日葵籽(SS;占日粮干物质的10%;n-6/n-3比例为4.6),要么是作为受保护n-3脂肪酸来源的Alifet-High Energy和Alifet-Repro混合物(AF;分别占日粮干物质的3.5%和1.5%;n-6/n-3比例为2.6)。从产奶第12天至70天,每隔10天给奶牛注射0(SSN、AFN)或500(SSY、AFY)mg的bST,此后每隔14天注射一次。在产奶第-12、10、24和136天采集肝脏活检样本进行基因表达分析。生长激素受体(GHR)、胰岛素样生长因子-I(IGF-I)、IGF结合蛋白-3(IGFBP3)、肝细胞核因子4α(HNF4α)、成纤维细胞生长因子-21(FGF-21)和过氧化物酶体增殖物激活受体α(PPARα)为目标基因,次黄嘌呤磷酸核糖基转移酶(HPRT)用作内参基因。通过对32头奶牛(8个完整组)中每组4个样本进行定量实时逆转录PCR分析来测定表达量。肝脏HPRT mRNA的量不受bST或日粮的影响,但在泌乳早期增加了约3.8%(产奶第-12、10、24和136天分别为3.42、3.52、3.54和3.41×10⁴个信息拷贝)。这种小变化对HPRT作为内参基因的能力几乎没有可检测到的影响。产犊后肝脏GHR、IGF-I和IGFBP3 mRNA的量减少了1.5至2倍。在注射bST后12天内(至产奶第24天),GHR和IGF-I的表达增加,IGFBP3的表达有增加趋势。bST的这些作用持续到产奶第136天。肝脏HNF4α mRNA不受产奶天数或任何处理的影响。PPARα mRNA的丰度在产奶第24天前未改变,但在产奶第136天增加。在产奶第24天至136天,bST、日粮和产奶天数对PPARα mRNA丰度存在交互作用趋势,因为在SSN、SSY和AFN组奶牛中PPARα mRNA的量增加,而在AFY组奶牛中未改变。FGF-21 mRNA的量在泌乳早期显著增加,但与HNF4α mRNA一样,不受bST、日粮或它们的交互作用影响。这些结果表明:1)在泌乳早期奶牛处于负能量平衡时,bST诱导肝脏GHR、IGF-I和IGFBP3表达增加;2)日粮n-6/n-3含量降低对肝脏基因表达无影响;3)支持肝脏FGF-21通过在泌乳早期解耦生长激素-IGF轴发挥潜在的同态调节作用。